When did FOOTOO take ivermectin? When did FOOTOO push it advise support it embrace it?
FYI LIB here means libertarian not liberal. Just in case you feel a need to correct me. When is a lib not a lib? When is a lib a lib? When can you both be/not be a lib?
Schroedinger's cat can answer that if you can catch him at the right moment.
The truth is that this is a rehash of earlier fake news. As of 28 August 2021, Ivermectin is NOT approved in Japan for use against COVID-19."
https://www.techarp.com/science/japan-ivermectin-covid-19/
"At least two states in India have turned to ivermectin to help manage their COVID-19 outbreaks, even as experts warn against doing so.
"... But the drug's efficacy for COVID-19 has not been proven in a large randomized controlled trial, and no prominent health group -- the NIH and the WHO among them -- has recommended the drug in treatment or prophylaxis."
https://www.medpagetoday.com/special-reports/exclusives/92644
"Haruo Ozaki, chairman of the Tokyo Metropolitan Medical Association, recommended urgent use of the drug at a press conference on the 9th, mainly to prevent the aggravation of home caregivers in order to respond to the spread of the new coronavirus infection. He emphasized that antiparasitic drugs such as "ivermectin" should be administered to corona-infected persons, saying that they have been shown to be effective in preventing aggravation overseas.
In addition to ivermectin, he called for the government to approve the use of the steroidal anti-inflammatory drug dexamethasone. Mr. Ozaki said, "(Both) have few side effects. I would like the government to consider treatment at the level of the family doctor."
Here is a study:
Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n = 2438; I2 = 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method. Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence. Low-certainty evidence suggested that there may be no benefit with ivermectin for “need for mechanical ventilation,” whereas effect estimates for “improvement” and “deterioration” clearly favored ivermectin use. Severe adverse events were rare among treatment trials and evidence of no difference was assessed as low certainty. Evidence on other secondary outcomes was very low certainty.
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
https://journals.lww.com/americantherapeutics/Fulltext/2021/08000/Ivermectin_for_Prevention_and_Treatment_of.7.aspx
"[A] study suggesting the treatment [against the Coronavirus with Ivermectin] is effective against the virus was withdrawn due to “ethical concerns”.
[...] The preprint study on the efficacy and safety of ivermectin – a drug used against parasites such as worms and headlice – in treating Covid-19, led by Dr Ahmed Elgazzar from Benha University in Egypt, was published on the Research Square website in November [2020].
[... A medical student found that] the introduction section of the paper appeared to have been almost entirely plagiarised. [...] It appeared that the authors had run entire paragraphs from press releases and websites about ivermectin and Covid-19 through a thesaurus to change key words.[Nick] Brown [a data analyst affiliated with Linnaeus University in Sweden] created a comprehensive document uncovering numerous data errors,
[https://steamtraen.blogspot.com/2021/07/Some-problems-with-the-data-from-a-Covid-study.html
] discrepancies and concerns, which he provided to the Guardian [a British newspaper]. According to his findings the authors had clearly repeated data between patients.
“The main error is that at least 79 of the patient records are obvious clones of other records,” Brown told the Guardian. “It’s certainly the hardest to explain away as innocent error, especially since the clones aren’t even pure copies. There are signs that they have tried to change one or two fields to make them look more natural.”
Other studies on ivermectin are still under way. In the UK, the University of Oxford is testing whether giving people with Covid-19 ivermectin
[https://www.bbc.com/news/health-57570377
] prevents them ending up in hospital."
Extracts source:
https://www.theguardian.com/science/2021/jul/16/huge-study-supporting-ivermectin-as-covid-treatment-withdrawn-over-ethical-concerns
- - - - End of extracts - - - -
[...] Experts said the trials that the study relies on are not high quality.
Dr. Amesh Adalja, a senior scholar at the Johns Hopkins University Center for Health Security, said the study is a meta-analysis (an analysis of other analyses) "whose strength is dependent on the underlying studies that comprise it."
"In general, most of the ivermectin studies that purport to show a positive benefit are of low quality and have potential sources of bias," which is why the drug is not recommended by the National Institutes of Health or the Infectious Diseases Society of America, he said. "It is only with rigorously designed randomized control trials that any true benefit can be discovered." [...]Gorski [Dr. David Gorski, a professor of surgery and oncology at Wayne State University and chief of breast surgery at the Karmanos Cancer Institute] also pointed out that the researchers, despite claiming to have no conflicts of interest, are affiliated with BIRD (British Ivermectin Recommendation Development) Group.
BIRD describes itself as "campaigning for the safe medicine ivermectin to be approved to prevent and cure COVID-19 around the world." [...]
Extract source:
https://www.politifact.com/article/2021/jun/30/what-know-about-pro-ivermectin-groups-study-toutin/
- - - - End of extract - - - -
my2cents 